SNWV

SANUWAVE Health Inc. (SNWV) Economic Moat Analysis (2026)

Invetso Score: 4.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Intangible Assets

Score: 5.2 (Moderate)

SNWV’s reported ROIC of 2.8% and ROCE of 3.7% indicate limited evidence that proprietary brands, patents, or regulatory assets are translating into durable pricing power versus peers.

The absence of disclosed 5-year margin and return averages in the provided metrics weakens confidence that any intangible advantage has been stable through a full cycle.

If SNWV relies on specialized know-how or regulated approvals, those assets appear insufficient today to lift returns materially above capital costs, unlike stronger peers with persistent excess returns.

No peer-level evidence in the provided data shows SNWV holding a clearly superior intangible position that would support sustained margin premium over 5–10 years.

Switching Costs

Score:

SNWV’s low ROIC suggests customers are not yet locked in strongly enough to generate high retention economics versus peers.

A cash conversion cycle of 174.3 days implies working-capital intensity, but that alone does not prove customer switching friction or contractual lock-in.

Without evidence of recurring revenue, embedded workflows, or high integration costs, switching costs appear present at most in a limited form relative to stronger software or platform peers.

The current metrics do not show the kind of retention-driven pricing power that would justify a high switching-cost moat score.

Network Effects

Score:

The provided data contain no indication of user-to-user, buyer-seller, or data-network flywheels that would compound value as the customer base expands.

Low returns on capital are inconsistent with a peer-leading network effect that would materially improve monetization or retention over time.

Unlike stronger platform peers, SNWV shows no evidence in the supplied metrics of ecosystem dependence or self-reinforcing adoption.

Based on the available evidence, network effects are not a meaningful source of moat durability today.

Cost Advantage

Score:

SNWV’s asset turnover of 1.20x suggests reasonable asset utilization, but it does not by itself demonstrate a structural cost advantage versus peers.

ROIC below 3% implies that any operating efficiency is not yet strong enough to create durable unit-cost superiority after capital charges.

The long cash conversion cycle points to working-capital drag, which weakens the case that SNWV can consistently underprice peers while preserving returns.

No provided evidence shows SNWV has a scale-driven procurement, manufacturing, or logistics advantage that would materially widen margins over 5–10 years.

Efficient Scale

Score:

The available metrics do not show that SNWV operates in a market where a small number of incumbents can profitably serve demand with limited room for entrants.

Low capital returns suggest the company has not yet converted any scale position into a durable barrier that would keep peers from competing effectively.

There is no evidence in the provided data of regulatory scarcity, capacity constraints, or fixed-cost absorption that would make the market naturally favorable to one or two players.

Compared with firms that benefit from entrenched infrastructure or monopoly-like local scale, SNWV’s efficient-scale protection appears limited.

Overall Score

Score:

SNWV shows no strong evidence of a durable moat in the supplied data, because returns are low, switching frictions are not clearly visible, and there is no sign of network or scale-based dominance versus peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on SANUWAVE Health Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →